Characteristics of Kikuchi-Fujimoto disease in children compared with adults

Tae Yeun Kim1, Kee-Soo Ha, Yunkyung Kim

  • 1Korea University School of Medicine, 73 Inchon-ro, Sungbuk-gu, Seoul, 136-705, Republic of Korea.

Insights

Kikuchi-Fujimoto disease (KFD) in children presents differently than in adults. While cervical lymphadenopathy is common in both, children experience more fever and rash, and less generalized lymphadenopathy.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Dermatology

Background:

  • Kikuchi-Fujimoto disease (KFD) is a rare, benign, self-limiting condition.
  • KFD is characterized by cervical lymphadenopathy and often affects young adults.
  • Increasing recognition of KFD in pediatric populations necessitates understanding its unique characteristics.

Purpose of the Study:

  • To delineate the distinct clinical features of KFD in pediatric patients.
  • To compare the presentation and outcomes of KFD in children versus adults.
  • To analyze epidemiological data of pediatric KFD cases.

Main Methods:

  • Retrospective review of medical records for pediatric KFD patients (<18 years) from 2001-2012.
  • Inclusion of worldwide published case reports of KFD.
  • Comparative analysis of 140 pediatric cases against 733 cases of all ages.

Main Results:

  • KFD in children shows a male predominance (1.4:1), unlike adult female predominance (2:1).
  • Pediatric KFD commonly features tender cervical lymphadenopathy, fever (82%), and rash (10%), which are more frequent than in adults.
  • Generalized lymphadenopathy is less common in children (1%) compared to adults (8%).
  • Leukopenia was observed in 50% of children versus 38% of adults.
  • Recurrence rates and autoimmune disease associations were similar between pediatric and adult KFD patients.

Conclusions:

  • Cervical lymphadenopathy remains the hallmark of KFD across all age groups.
  • Pediatric KFD exhibits a distinct clinical profile with higher incidences of fever and rash.
  • Understanding these pediatric-specific features aids in accurate diagnosis and management of KFD in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.